Related Experiment Video
Updated: Apr 12, 2026
12:36
Single-cell Analysis of Immunophenotype and Cytokine Production in Peripheral Whole Blood via Mass Cytometry
Published on: June 26, 2018
10.0K
New monogenic autoinflammatory diseases--a clinical overview
Scott W Canna1, Raphaela Goldbach-Mansky
1Autoinflammatory Pathogenesis Unit, National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH, Bldg. 10, room 13c103, 10 Center Dr., Bethesda, MD, 20892, USA, scott.canna@nih.gov.
Seminars in Immunopathology
|May 13, 2015
Summary
Recent autoinflammatory disease research reveals new therapeutic targets beyond IL-1, including type I interferon and IL-18. Understanding these pathways improves diagnosis and treatment for complex genetic autoinflammatory syndromes.
Area of Science:
- Immunology
- Genetics
- Rheumatology
Background:
- Autoinflammatory diseases are genetic disorders characterized by inappropriate inflammation.
- Therapies targeting Interleukin-1 (IL-1) have shown success, but some patients remain unresponsive.
- Recent genetic discoveries are uncovering new inflammatory pathways involved in these conditions.
Purpose of the Study:
- To review recent advancements in understanding autoinflammatory disease mechanisms beyond IL-1.
- To highlight novel inflammatory mediators and pathways implicated in these disorders.
- To explore the connections between autoinflammation, autoimmunity, and immunodeficiency.
Main Methods:
- Review of recent genetic discoveries in monogenic autoinflammatory diseases.
- Analysis of clinical phenotypes associated with novel genetic defects.
- Synthesis of current knowledge on inflammatory mediators and signaling pathways.
Main Results:
- Identification of chronic type I interferon (IFN) production as a cause of distinct autoinflammatory syndromes.
- Association of high IL-18 production with macrophage activation syndrome.
- Recognition of nonhematopoietic cell pathway dysregulation in organ-specific autoinflammation.
Conclusions:
- New genetic insights reveal type I IFNs and IL-18 as key players in autoinflammation.
- Understanding nonhematopoietic cell involvement clarifies organ specificity.
- These discoveries offer new avenues for diagnosing and treating complex autoinflammatory diseases.
Related Concept Videos
01:29Autoimmune Disorders
2.3K
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
2.3K
01:30Inflammatory Bowel Disease II: Crohn's Disease
1.6K
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.6K
01:17Chronic Bowel Disorders: Introduction
950
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
950
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
1.5K
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.5K
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
800
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
800
01:29Inflammatory Bowel Disease IV: Pharmacological Management
986
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
986